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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
04.09.20 Azithromycin 
in addition to 
standard of 
care versus 
standard of 
care alone in 
the 
treatment of 
patients 
admitted to 
the hospital 
with severe 
COVID-19 in 
Brazil 
(COALITION 
II): a 
randomised 
clinical trial 
The Lancet | 
Article 
• In patients with severe 
COVID-19, adding 
azithromycin to standard 
of care treatment (which 
included 
hydroxychloroquine) did 
not improve clinical 
outcomes. Our findings 
do not support the routine 
use of azithromycin in 
combination with 
hydroxychloroquine in 
patients with severe 
COVID-19. 
azithromycin 
02.09.20 A neutrophil 
activation 
signature 
predicts 
critical 
medRxiv pre-
print (not 
peer-
reviewed) 
• Immune cells called 
neutrophils are more 
likely to be primed for 
action in people who will 
eventually develop 
severe COVID-19 than in 
those who are will go on 
neutrophils 
illness and 
mortality in 
COVID-19 
to become only mildly ill, 
according to a machine-
learning analysis of data 
from 3,300 people. If the 
results can be 
reproduced, they could 
aid early identification of 
the people most likely to 
become critically ill. 
01.09.20 Humoral 
Immune 
Response to 
SARS-CoV-
2 in Iceland 
NEJM | Article 
• Results indicate that 
antiviral antibodies 
against SARS-CoV-2 did 
not decline within 4 
months after diagnosis. 
We estimate that the risk 
of death from infection 
was 0.3% and that 44% 
of persons infected with 
SARS-CoV-2 in Iceland 
were not diagnosed by 
qPCR. 
  
03.09.20 The 
Immunology 
of 
Multisystem 
Inflammatory 
Syndrome in 
Children with 
COVID-19 
Cell | Journal 
pre proof 
• Researchers found that 
compared with children 
with Kawasaki’s disease, 
those with MIS-C have 
lower levels of an 
immune chemical called 
IL-17A, which has been 
implicated in inflammation 
and autoimmune 
disorders. 
• Unlike all the other 
children studied, children 
with MIS-C had no 
antibodies to two 
coronaviruses that cause 
the common cold. This 
deficit might be implicated 
in the origins of their 
condition, the authors 
say. 
Multisystem 
Inflammatory 
Syndrome 
  
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
02.09.20 Association 
Between 
Administration of 
Systemic 
Corticosteroids 
and Mortality 
Among Critically 
Ill Patients With 
COVID-19 
JAMA | Article 
• In this 
prospective 
meta-analysis of 
7 randomized 
trials that 
included 1703 
patients of whom 
647 died, 28-day 
all-cause 
mortality was 
lower among 
patients who 
received 
corticosteroids 
compared with 
those who 
received usual 
care or placebo 
Corticosteroids 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
09.09.20 Early indirect 
impact of 
COVID-19 
pandemic on 
utilization 
and 
outcomes of 
reproductive, 
maternal, 
newborn, 
child and 
adolescent 
health 
services in 
Kenya 
medRxiv pre-
print (not 
peer-
reviewed) 
• Data for the first four 
months (March-June) of 
the pandemic and the 
equivalent period in 2019 
were extracted from 
Kenya Health 
Information System. 
• Conclusion: COVID-19 
may have contributed to 
increased adolescent 
pregnancy, adolescent 
maternal death and 
stillbirth rates in Kenya. If 
this trend persists, recent 
gains achieved in 
maternal and perinatal 
health in Kenya will be 
lost. With uncertainty 
around the duration of 
the pandemic, strategies 
to mitigate against 
catastrophic indirect 
maternal health 
COVID-19, 
maternal, 
reproductive, 
stillbirths, 
family 
planning, 
adolescent, 
mortality, 
Kenya 
outcomes are urgently 
needed. Key words: 
COVID-19, maternal, 
reproductive, stillbirths, 
family planning, 
adolescent, mortality, 
Kenya. 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
09.09.20 Projected 
health-
care 
resource 
needs for 
an 
effective 
response 
to COVID-
19 in 73 
low-
income 
and 
middle-
income 
countries: 
a 
modelling 
study 
Lancet Global 
Health | 
Article 
• This study aimed to identify 
what the additional health-
care costs of a strategic 
preparedness and response 
plan (SPRP) would be if 
current transmission levels 
are maintained in a status quo 
scenario, or under scenarios 
where transmission is 
increased or decreased by 
50%. 
• The number of COVID-19 
cases was projected for 73 
low-income and middle-
income countries for each of 
the three scenarios for both 4-
week and 12-week 
timeframes, starting from June 
26, 2020. 
• Conclusion: The sizeable 
costs of a COVID-19 
response in the health sector 
will escalate, particularly if 
transmission increases. 
Instituting early and 
comprehensive measures to 
limit the further spread of the 
virus will conserve resources 
and sustain the response. 
health 
  
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
08.09.20 Covid-19: Key Considerations for a Public 
Health Response 
Institute of Development Studies 
07.09.20 Covid-19: UK studies find gastrointestinal 
symptoms are common in children 
BMJ | News 
09.09.20 Severe COVID-19 riskier than heart attack 
for young adults; antibiotic shows no benefit 
Reuters research round up 
05.09.20 Is India missing COVID-19 deaths? Lancet | World Report 
01.09.20 A locally sustainable approach to COVID-19 
testing in Africa 
The Lancet | Correspondence 
07.09.20 Legal agreements: barriers and enablers to 
global equitable COVID-19 vaccine access 
The Lancet | Comment 
04.09.20 COVID-19 vaccine trials in Africa The Lancet | News 
03.09.20 India will supply coronavirus vaccines to the 
world — will its people benefit? 
Nature | News 
05.09.20 COVID-19 exacerbates violence against 
health workers 
The Lancet | World Report 
01.09.20 Will the COVID-19 crisis trigger a One 
Health coming-of-age? 
The Lancet Planetary Health | 
Comment 
09.09.20 COVID-19 could reverse decades of 
progress toward eliminating preventable 
child deaths, agencies warn 
WHO news 
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Dashboards & Trackers 
Cases & deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO dashboard  African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials 
Registry Platform 
(ICTRP)  
 FIND SARS-
CoV-2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria CDC  Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra Leone   Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, University 
of Oxford  
  US   COVID-19 
Primer 
Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker                
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C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
COVID-19 
Digest 
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
FutureLearn 
LSHTM/UK PHRST 
weekly 
study 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from 
bioRxiv and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All 
primary research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, 
and disease control and health system responses are included. Articles related to tackling the secondary impacts 
on other sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected 
based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Foreign, Commonwealth 
and Development Office (FCDO) and its partners in support of pro-poor programmes. Except 
where otherwise stated, it is licensed for non-commercial purposes under the terms of the 
Open Government Licence v3.0. K4D cannot be held responsible for errors, omissions or 
any consequences arising from the use of information contained in this health evidence 
summary. Any views and opinions expressed do not necessarily reflect those of FCDO, K4D 
or any other contributing organisation.  
© Crown copyright 2020. 
  
 
 
